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1. Introduction 
Sphingolipids are essential structural components of cellular membranes, playing 
prominent roles in signal transduction that governs cell proliferation, differentiation, 
migration, and apoptosis. Most sphingolipids are ubiquitous, but complex sphingolipids, 
including sphingomyelin (SM) and glycosphingolipids (GSLs), are more abundant in the 
brain and are particularly abundant in myelin. Sphingolipids are defined by the presence of 
a long-chain sphingoid backbone, generally sphingosine. Acylation of the sphingoid base, 
i.e. addition of a C14–C26 fatty acid to the amino group, yields ceramide, a building block for 
more complex sphingolipids. Neural cells are particularly enriched in GSLs and SM which is 
also a major lipid component of myelin. Sphingolipids are abundant in the plasma 
membranes and have unique molecular structures and conformational properties that cause 
them to form segregated compositional lipid domains in phospholipid bilayers (Sonnino et 
al., 2006). Membrane lipid domains, zones of the membrane with reduced fluidity, contain 
complex lipids of the cell, but are highly enriched in cholesterol and sphingolipids. 
Importantly, the proteins involved in signal transduction appear to segregate also in the 
lipid domains where they can exert their functions.  Experimental evidence indicating that 
sphingolipids function through membrane reorganization and formation of lipid domains is 
summarized in a recent review by Kolesnick and Stancevic (Stancevic and Kolesnick, 2010). 
In addition to their role as building blocks of cellular membranes, sphingolipids have been 
reported to be pleotropic modulators of numerous enzymes in intracellular signaling 
pathways. Basic organization and specific principles of sphingolipid-mediated cell 
regulation have been reviewed by Hannun and Obeid (Hannun and Obeid, 2008, 2011).  
After more than a decade of extensive investigations, it has become clear that ceramide is a 
key sphingolipid messenger regulating a diverse range of cell-stress responses, including 
apoptosis, cell senescence, and autophagy. Ceramide is tightly regulated in cells, and its 
participation in cell death signaling pathways is controlled by rapid conversion of ceramide 
into less deleterious sphingolipids (Scheme 1). Thus, ceramide can be metabolized into 
complex sphingolipids by glucosylceramide synthase or into SM by SM synthase, or into 
ceramide-1-phosphate by ceramide kinase (Hannun and Obeid, 2002; Ogretmen and 
Hannun, 2004), or into sphingosine-1-phosphate by ceramidase and sphingosine kinase 
(Hannun and Obeid, 2008). However, pathological conditions, including cerebral 
ischemia/reperfusion, could disturb ceramide metabolism resulting in ceramide 
accumulation that ultimately leads to cell death. 
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2. Pathways of ceramide generation 
Ceramide is a family comprised of about 50 distinct molecular species characterized by 
various acyl chains, their desaturation, and hydroxylation. Ceramide is an N-
acylsphingosine consisting of a fatty acid bound to the amino group of the sphingoid base, 
sphingosine. Ceramides can contain monounsaturated or saturated fatty acids of various 
lengths from 2 to 28 carbon atoms, and the fatty acid chain length profoundly alters 
ceramide’s biophysical properties. Short-chain ceramides with fatty acyl chains of fewer 
than 12 carbons can be easily dispersed in water and serve as detergents (Sot et al., 2005b). 
In contrast, most ceramides found in mammalian cellular membranes contain long fatty acyl 
chains of 16-28 carbon atoms rendering them hydrophobic lipids lacking detergent 
properties. Short-chain ceramides mix much better with phospholipids, promote a positive 
curvature in lipid monolayers, and their capacities to increase bilayer permeability or 
transbilayer motion are very low or non-existent. In situ enzymatic generation, or external 
addition, of long-chain ceramides in membranes has at least three important effects: (i) the 
lipid monolayer has an increased tendency to adopt a negative curvature, e.g. through a 
transition to an inverted hexagonal structure (Graham and Kozlov, 2010), (ii) the bilayer 
permeability to aqueous solutes is notoriously enhanced, and (iii) a transbilayer (flip-flop) 
lipid motion is promoted (Goni et al., 2005).  
As a result, ceramide metabolism is restricted to cellular membranes and is highly 
compartmentalized. Hydrophobic ceramides are generated by membrane-associated 
enzymes, and exert their effects either in close proximity to the generation site or require 
specific transport mechanisms to reach their targets in another intracellular compartment 
(Futerman and Riezman, 2005). Long-chain ceramides appear to be able to flip-flop across 
the membrane (Lopez-Montero et al., 2005); however, spontaneous inter-bilayer transfer is 
extremely slow (Contreras et al., 2010). Therefore, the transfer of ceramide between 
intracellular compartments is facilitated by vesicular transport pathways (Perry and 
Ridgway, 2005). Alternatively, ceramide is transported by a non-vesicular pathway 
involving a transfer protein, CERT, from its generation site in the endoplasmic reticulum 
(ER) to the Golgi where it is required for SM synthesis (Hanada et al., 2003). In addition to de 
novo biosynthesis, ceramide is generated by sphingomyelinases (SMases) from SM in two 
major pathways: the neutral SMase (nSMase)-dependent pathway and aSMase (aSMase)-
dependent pathway or salvage (recycling) pathway (Scheme 1). 
2.1 De novo ceramide biosynthesis 
Remarkable progress has been made toward identifying enzymes involved in ceramide 
biosynthesis (Futerman and Riezman, 2005). (Dihydro) ceramide synthase (EC 2.3.1.24) is a 
key enzyme in de novo ceramide synthasis, and it utilizes fatty acid acyl CoA for N-acylation 
of sphinganine (dihydrosphingosine) yielding dihydroceramide that is converted to 
ceramide by desaturase (Scheme 1). In yeast, longevity assurance gene 1 (LAG1) was 
identified as a component of ceramide synthase. Deletion of LAG1 in haploid cells resulted 
in a pronounced increase (~50%) in mean and maximum life spans (D'Mello N et al., 1994).  
Mammalian homologs of LAG1, which belong to the LASS (longevity assurance gene 
homolog) family, were cloned and characterized (Futerman and Riezman, 2005). Each of the 
6 known LASS (also known as CerS) genes appears to regulate synthesis of a specific subset 
of ceramides, and displays a unique substrate specificity profile for chain-length and/or 
saturation in fatty acid acyl CoA. Over-expression of any CerS protein in mammalian cells 
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Scheme 1. Biosynthesis of ceramide and its conversion into other bioactive sphingolipids.  
De novo ceramide synthesis begins with the conversion of serine and fatty acyl CoA into 3-
ketosphinganine by serine palmitoyl transferase (SPT), then 3-ketosphinganine is converted 
into dihydrosphingosine. Myriocin is a potent inhibitor of SPT activity. (Dihydro) ceramide 
synthase (LASS/CerS) acylates dihydrosphingosine to form dihydroceramide, which is then 
reduced to ceramide by dihydroceramide desaturase. Ceramide is also produced by SMases 
through SM degradation in SMase pathway. Ceramidase converts ceramide into 
sphingosine, which is phosphorylated by sphingosine kinase (SK) to generate sphingosine-
1-phosphate. Ceramide is phosphorylated by ceramide kinase (CK) yielding ceramide-1-
phosphate (C1P). In the salvage or recycling pathway, complex sphingolipids are broken 
down to ceramide by glucosylceramidase (GCase) and then by ceramidase to sphingosine, 
which is re-acylated to ceramide by LASS/CerS. Fumonisin B1 inhibits LASS/CerS activity. 
resulted in increased levels of a specific subset of ceramide species. It has been demonstrated 
that CerS1 exhibits high specificity for C18:0-CoA generating C18:0-ceramide (Mizutani et al., 
2005). CerS2, CerS4, and CerS3 appear to have broader specificity (Laviad et al., 2008; Mizutani 
et al., 2006). CerS2 or CerS4 mainly synthesizes C20:0-, C22:0-, C24:1-, C24:0-, C26:1 and C26:0 ceramide, 
but is unable to synthesize C16:0- or C18:0-ceramide (Laviad et al., 2008; Mizutani et al., 2005). 
CerS3 generates C18:0-, C20:0-, C22:0- and C24:0-ceramide (Mizutani et al., 2006). It has been shown 
that CerS5 generates C14:0-, C16:0-, C18:0-, and C18:1-ceramide (Lahiri and Futerman, 2005; Mizutani 
et al., 2005); and CerS6 produces C14:0-, C16:0-, and C18:0-ceramide (Mizutani et al., 2005).  
The availability of certain fatty acyl-CoA species and the characteristic distribution pattern 
of CerS family members in tissues seem to regulate the tissue-specificity of the ceramide 
species. Northern blot and real-time RT-PCR analysis revealed broad expression of CerS5, 
CerS4, and CerS6 genes in mammalian tissues, but CerS1 expression was limited to the brain 
and skeletal muscle (Laviad et al., 2008; Mizutani et al., 2006). Interestingly, CerS2 mRNA 
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was more abundant than other CerS family members and had the broadest tissue 
distribution (Laviad et al., 2008). Except for a weak display in skin, CerS3 mRNA expression 
is limited almost solely to testis, implying that CerS3 plays an important role in this gland 
(Mizutani et al., 2006).  
CerS are integral membrane proteins, but the exact number of transmembrane domains and 
their topology has not been resolved experimentally. All of the CerS genes have a highly 
conserved stretch of 52 amino acids known as the Lag1p motif which is essential for enzyme 
activity (Spassieva et al., 2006). Some of the CerS proteins are post-translationally modified, 
and, for instance, CerS6 is expressed as a native and an N-glycosylated form. The N-
glycosylation site is conserved in CerS6, CerS2, and CerS5, but this post-translational 
modification is not required for ceramide synthase activity (Mizutani et al., 2005). 
Intriguingly, CerS1 phosphorylation appears to regulate the protein turnover (Sridevi et al., 
2009). All CerS except CerS1 contain a homeobox domain, suggesting involvement in 
developmental regulation (Venkataraman and Futerman, 2002). De novo synthesis of 
ceramide is required for cell survival in vivo, and is widespread among cell types and 
tissues. Regulation of ceramide synthesis is only beginning to be understood. Regulation at 
the transcriptional level has been observed with a number of agents, including endotoxin 
and cytokines, UVB irradiation, and retinoic acid (Merrill, 2002). 
De novo ceramide biosynthesis occurs in the endoplasmic reticulum (ER) where all the 
participating enzymes have been found (Hirschberg et al., 1993; Mandon et al., 1992; Michel 
and van Echten-Deckert, 1997). Ceramide is synthesized at the cytosolic side of the ER 
(Mandon et al., 1992; Merrill, 2002), serving as a precursor for the biosynthesis of 
glycosphingolipids and SM in the Golgi (Futerman et al., 1990; Kolter et al., 2002).  
2.2 Sphingomyelin hydrolysis 
SM hydrolysis by one of several SMases is another source of cellular ceramide. Three groups 
of SMases, acid, neutral, and alkaline, are distinguished by their primary structure, catalytic 
pH optimum, and localization.  
2.2.1 Acid SMase  
A well-characterized enzyme, acid SMase (aSMase) contributes to the catabolism of SM and 
ceramide formation in lysosomes (Tani et al., 2005; Tani et al., 2007). aSMase could relocate 
from intracellular compartments to the plasma membrane where it plays an important role 
in SM hydrolysis and ceramide generation within lipid rafts (Bollinger et al., 2005). aSMase 
is a soluble enzyme with no transmembrane domains, and the mechanism of aSMase 
association with the membrane, at which its substrate, SM, resides, remains unclear. aSMase 
is also secreted through the Golgi secretory pathway, and it is constitutively present in 
plasma (Spence et al., 1989) where it is involved in hydrolysis of lipoprotein-bound SM, the 
second most abundant lipid in human plasma. Intriguingly, aSMase hydrolyzes SM bound 
to oxidized LDL more effectively than SM bound to intact LDL (Schissel et al., 1998). The 
accelerated hydrolysis of SM could enhance LDL aggregation leading to macrophage foam 
cell formation, suggesting a role for secretory aSMase in the pathogenesis of arteriosclerosis 
(Tabas, 1999).  
2.2.2 Neutral SMase  
Three mammalian closely related isoforms of neutral SMase (nSMase) have been recently 
cloned, including nSMase1, nSMase2 and mitochondria-associated nSMase (MA-nSMase) 
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(Clarke et al., 2011). nSMase1 is localized to the ER and nucleus (Tomiuk et al., 2000). 
nSMase2 had a dynamic intracellular localization (Clarke et al., 2006), having been found in 
the Golgi of sub-confluent cells, at the plasma membrane at the regions of cell-cell contact 
(Marchesini et al., 2004) and in recycling compartments (Milhas et al., 2010). Furthermore, it 
appears that oxidative stress could induce nSMase2 trafficking to the plasma membrane, 
whereas antioxidant (glutathione) directed its translocation to the perinuclear region (Levy 
et al., 2006). MA-nSMase is found within the mitochondria and associated membranes (Wu 
et al., 2010). The physiological role of neutral SMase isoforms may be dictated by their 
immediate environment in the specific intracellular compartment. Alkaline SMase lacks 
homology to neutral or aSMase and its mRNA is abundant in the intestine where the 
enzyme plays a major role in digestion of dietary SM (Nilsson and Duan, 2006). 
2.3 Recycling or salvage pathway  
Ceramide is also produced during the recycling of sphingosine in the process termed the 
“salvage pathway” (Kitatani et al., 2008). In this process, complex sphingolipids are broken 
down to ceramide and then to sphingosine, which is then used by ceramide synthase to 
yield ceramide. SM is converted to ceramide by aSMase. Ceramide accumulation via the 
salvage pathway requires ceramide synthase which is important in de novo synthesis of 
ceramide. Complex sphingolipids undergo constitutive degradation in the late endosomes 
and the lysosomes yielding ceramide which does not leave the lysosomes (Chatelut et al., 
1998) unless converted into sphingosine by acid ceramidase. Free sphingosine could be 
released from the lysosomes and re-acylated by ceramide synthase to form ceramide.  
3. Ceramide generation in mitochondria 
Mitochondria arise as important intracellular compartment for ceramide metabolism, and 
they have been shown to contain a variety of sphingolipids, including SM and ceramide 
(Ardail et al., 2001; Tserng and Griffin, 2003). Mounting evidence suggests a local action of 
ceramide on mitochondria in intact cells. Thus, selective hydrolysis of a mitochondrial pool 
of SM by overexpressed sphingomyelinase (bSMase) targeted to mitochondria resulted in 
apoptosis. In contrast, generation of ceramide in the plasma membrane, ER, or Golgi 
apparatus by bSMase targeted to these compartments had no effect on cell viability (Birbes 
et al., 2001). Recently, mitochondrial ceramide engagement in apoptosis has been shown 
using loss-of-function mutants of ceramide synthase in the germ cell line of C. elegans (Deng 
et al., 2008). In this study, an ionizing radiation-induced apoptosis of germ cells was 
obliterated upon inactivation of ceramide synthase, and restored upon microinjection of 
long-chain ceramide. Radiation-induced increase in ceramide localized to mitochondria was 
required for activation of CED-3 caspase and apoptosis. These studies underscore the 
physiological significance of the mitochondrial ceramide and SM pools (Andreyev et al., 
2010; Ardail et al., 2001; Dai et al., 2004; Monette et al., 2010; Tserng and Griffin, 2003; Yabu 
et al., 2009). 
Although several enzyme activities involved in ceramide metabolism have been 
demonstrated in mitochondria, the nature of enzymes generating ceramide in this organelle 
is still a matter of debate (Laviad et al., 2008). Mitochondria evolve as a specialized 
compartment of sphingolipid metabolism with their own subset of ceramide synthesizing 
and degrading enzymes. Three possibilities may account for ceramide generation in 
mitochondria.  
www.intechopen.com
 
Advances in the Preclinical Study of Ischemic Stroke 
 
274 
First, experimental evidence suggests the presence of ceramide synthase activity in 
mitochondria. Thus, ceramide synthase activity was first detected (Morell and Radin, 1970; 
Ullman and Radin, 1972) and partially purified from a bovine brain mitochondria-enriched 
fraction (Shimeno et al., 1995) which was not characterized in terms of marker enzyme 
activities. Mitochondrial enzymes had almost 2-fold higher specific ceramide synthase 
activity than the ceramide synthase from the ER. The mitochondrial enzyme had a pH 
optimum around 7.5 and maximal catalytic efficiency with C16:0- or C18:0-acyl CoA. The 
addition of liposomes to the mitochondrial enzyme increased ceramide synthase activity 
(approx. 7.8-fold) (Shimeno et al., 1995). Purification of ceramide synthase from bovine liver 
mitochondria yielded two major protein bands, 62 and 72 kDa on a SDS-gel (Shimeno et al., 
1998). This enzyme had an apparent Km of 146 µM and Vmax of 11.1 nmol/min/mg protein 
with C18:0-acyl CoA, and corresponding values of Vmax 144 µM and 8.5 nmol/min/mg 
protein towards sphinganine.  
Detailed analysis of ceramide synthase activity in highly purified mitochondria by Bionda et al. 
essentially confirmed previous findings (Bionda et al., 2004). Ceramide synthase activity was 
demonstrated in rat liver mitochondria and in the sub-compartment of the ER closely 
associated with mitochondria. Further sub-mitochondrial investigation of ceramide synthase 
activity revealed that both outer and inner mitochondrial membranes can synthesize ceramide 
(Bionda et al., 2004). Recent reports describing several ceramide synthase isoforms, including 
CerS1, CerS2, CerS4 and CerS6, in purified mouse brain mitochondria (Novgorodov et al., 
2011a; Yu et al., 2007) support the notion that several ceramide synthesizing enzymes could be 
localized in mitochondria (Futerman, 2006). No such association was found in HeLa cells 
(Mesicek et al., 2010), suggesting that this might be a cell type/tissue specific event. The intra-
mitochondrial localization of CerS was examined in purified brain mitochondria by 
immunoprecipitation (Novgorodov et al., 2011a). These studies reveal a selective CerS6 
association with adenine nucleotide translocase, the inner membrane component of the 
mitochondrial permeability transition pore (MPTP). In contrast, CerS2 associated with the 
outer membrane resident protein Tom20, a receptor of the protein import complex. The data 
suggest CerS6/ceramide could regulate MPTP activity and mitochondrial Ca2+ homeostasis 
whereas CerS2/ceramide could modulate the mitochondrial protein import machinery.  
Secondly, recent studies identified two novel SMases, which hydrolyze SM to ceramide, and 
phosphocholine in mitochondria from zebrafish (Yabu et al., 2009) and mouse tissues (Wu et 
al., 2010). Notably, in yeast, the mammalian nSMase ortholog Isc1p associates with 
mitochondria in the post-diauxic phase of yeast growth and regulates mitochondrial 
sphingolipid metabolism (Kitagaki et al., 2007; Vaena de Avalos et al., 2004). 
Thirdly, the additional source of ceramide in mitochondria is a reverse reaction of a neutral 
ceramidase (nCDase), e.g., formation of ceramide as a result of condensation of palmitate 
and sphingosine (El Bawab et al., 2001). On the basis of molecular cloning and confocal 
microscopy data, this activity was ascribed to mitochondria (El Bawab et al., 2000), and it 
was demonstrated in purified mitochondria (Bionda et al., 2004). Recent studies describe the 
molecular mechanism of ceramide generation from palmitate and sphingosine in purified 
liver mitochondria that requires concerted action of two enzymes nCDase and thioesterase 
(which hydrolyzes palmitoyl-CoA to CoA and fatty acid)(Novgorodov et al., 2011b).  Thus, 
mitochondria from nCDase-deficient mice have significantly decreased formation of 
ceramide from sphingosine and palmitoyl-CoA (or palmitate) compared to mitochondria 
from wild type mice, indicating that nCDase participates in ceramide formation in liver 
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mitochondria, and that ceramide formation may occur from sphingosine and palmitoyl-CoA 
from coupled activities of a mitochondrial thioesterase and nCDase catalyzing the reverse 
reaction (Scheme 2). Another possibility is that ceramide could be also transported from the 
ER to mitochondria through the contact sites between them (Stiban et al., 2008). 
 
Acyl-CoA
FFA
CoA
Sph
ceramide
MTENCD
Mitochondrial membrane
 
Scheme 2. Ceramide formation from Acyl-CoA and sphingosine (Sph) mediated by coupled 
activities of mitochondrial thioesterase (MTE) and nCDase (NCD). 
4. Ceramide accumulation in Ischemia/Reperfusion (IR) 
Ceramide accumulation has been demonstrated in various in vivo models of IR and it has 
been implicated as an important mediator of apoptosis in the injured tissue, but mechanisms 
of ceramide generation are not well-defined and the downstream targets of ceramide remain 
unresolved. The IR-induced accumulation of ceramide appears to be a general phenomenon 
for heart, kidney, liver and brain. The identification and characterization of key proteins of 
ceramide synthesis are expected to expand our understanding of molecular mechanisms 
behind ceramide’s involvement in IR-induced tissue damage. 
Research progress has been hampered by a lack of appropriate techniques that would allow 
simultaneous analysis of multiple sphingolipid species. Thus, the most common method for 
quantification of ceramide, the diglyceride (DG) kinase assay (Bielawska et al., 2001) has 
significant disadvantages including a limited separation of ceramide from dihydroceramide 
and the inability to determine the individual molecular species of ceramide. Recent 
advances in the development of new mass spectroscopy-based methods for quantitative 
analysis of sphingolipid molecular species may allow further dissection of ceramide specific 
pathways (Pettus et al., 2004; Sullards, 2000).  
Increasing evidence suggests that the fatty acid chain of ceramide is an important 
determinant of the biological effect mediated by the individual ceramide species. Most of 
the experimental evidence indicating the important roles of ceramides containing distinct 
fatty acids is summarized in an excellent review by Futerman and his colleagues (Pewzner-
Jung et al., 2006), and new studies further support the notion of distinct roles of ceramide 
species in cell metabolism(Hannun and Obeid, 2011). It has been demonstrated that 
generation of C18:0-ceramide, and not C16:0-ceramide repressed human telomerase reverse 
transcriptase promoter in lung carcinoma cells (Wooten-Blanks et al., 2007). Activation of 
aSMase in the salvage pathway brought about a selective accumulation of C16:0-ceramide 
(Chudakova et al., 2008; Kitatani et al., 2006) due to the involvement of ceramide synthase 
CerS5 localized in mitochondria-associated membranes (Kitatani et al., 2006). In another 
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study, the effects of chronic hypoxia on selected ceramide species were examined in cardiac 
tissue in a neonatal mouse model (Noureddine et al., 2008). The study revealed the 
differential involvement of the right ventricle with regard to levels of C16:0-ceramide and its 
precursor, dihydro-C16:0-ceramide. The decrease in C16:0-ceramide observed in both hypoxic 
and control right ventricles over time occurred along with a significant increase in dihydro-
C16:0-ceramide in hypoxic but not control tissues suggesting a role for dihydro-C16:0-
ceramide in the adaptive tissue response to hypoxia. Although ceramide species could have 
different effects on biophysical properties of the membrane lipid bilayer (Sot et al., 2005a), it 
remains unclear how ceramides containing different fatty acids exert their effects upon cell 
physiology.  
4.1 Cardiac ischemia 
In several studies, elevated ceramide has been reported in myocardium after ischemia and 
IR. In the rat heart left coronary artery occlusion model, ischemia with subsequent 
reperfusion, but not ischemia alone, induced apoptosis in myocardial cells indicated by 
DNA laddering and measurement of soluble chromatin degradation products (Bielawska et 
al., 1997). The content of ceramide in ischemic myocardium was elevated to 155% baseline 
levels after 30 min ischemia, and was further increased to 250% after 3 h reperfusion. In the 
rabbit heart left coronary artery occlusion model, ceramide content was increased during the 
first minute of ischemia, peaking at 5 min with mean ceramide ~127% of baseline. However, 
this peak was transient because ceramide content returned to near-baseline values as soon 
as 10 min into the sustained ischemia (Argaud et al., 2004). In another study with the rat 
heart left coronary artery occlusion model, ceramide content in reperfused myocardium was 
found to increase up to 50%. This increase was not associated with enhanced neutral or 
aSMase activity, but rather with reduced activity of ceramidase, a ceramide-metabolizing 
enzyme (Scheme 1) (Zhang et al., 2001). In a global rat heart ischemia model, ceramide 
content was elevated about 2-fold after 30 min ischemia/30 min reperfusion which was 
attributed to SM hydrolysis. Thus, there was about 50% less SM in reperfused myocardium 
after IR (Cordis et al., 1998). This finding was confirmed in recent studies by the same group 
who reported an increased accumulation of ceramide in ischemic myocardium after 30 min 
ischemia/2 h reperfusion (Cui et al., 2004; Der et al., 2006). An inhibitor of aSMase activity 
desipramine prevented ceramide accumulation and provided cardioprotection. Intriguingly, 
a significant amount of ceramide accumulated in the caveolin-1-rich membrane 
microdomains after IR was abolished by pre-treatment with desipramine (Der et al., 2006). 
The ceramide–caveolin-1 interaction is believed to occur within lipid raft microdomains in 
membranes leading to rafts stabilization (Xu et al., 2001) and alteration of receptor tyrosine 
kinase signal transduction (Zundel et al., 2000).  
In a very interesting study, analysis of cardiac tissues from mice subjected to IR revealed 
significant elevation of ceramide and inhibition of sphingosine kinase 1 activity (Scheme 1) 
that could ultimately result in decreased sphingosine-1-phosphate (Pchejetski et al., 2007). 
Furthermore, sphingosine kinase 1 inhibition, ceramide accumulation, cardiomyocyte 
apoptosis, and infarct size were significantly decreased in mitochondrial monoamine 
oxidase (MAO-A)-deficient mice after IR. MAO-A appears to play an important role in 
reactive oxygen species (ROS)-dependent cardiomyocytes apoptosis and postischemic 
cardiac damage (Bianchi et al., 2005). The data imply that the upregulation of 
ceramide/sphingosine-1-phosphate ratio is a critical event in MAO-A-dependent cardiac 
cell apoptosis in IR. 
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Recently, increases of specific ceramide species in the rat heart were investigated after 30 
min global ischemia/30 min reperfusion. IR increased accumulation of only 7 out of 14 
ceramide species identified in the heart (Beresewicz et al., 2002). Of note, the relative 
magnitude of IR-induced myocardial accumulation of ceramide species was not 
proportional to their basal tissue concentrations. For instance, although C16:0-ceramide and 
C18:0-ceramide are the most abundant in rat heart (40% and 23% of total, respectively), IR 
increased their content by 48–54%. However, C18:2-ceramide, which contributes only 3.2% of 
total myocardial ceramides, was increased by 281%. These findings suggest the role of 
specific ceramide species signaling in the mechanism of post-ischemic myocardial injury. 
In vitro, hypoxia/reoxygenation activated nSMase and ceramide accumulation in 
cardiomyocytes implicating the production of free radicals (Hernandez et al., 2000). nSMase 
activation could be abrogated by inhibition of a factor associated with nSMase activation 
(FAN) which is an adaptor protein connecting neutral SMase to the TNF receptor signaling 
pathway (O'Brien et al., 2003).  
4.2 Liver ischemia 
Ceramide was elevated in injured liver tissue after cold ischemia and warm reperfusion 
during liver transplantation (Bradham et al., 1997). A critical role of aSMase and ceramide 
accumulation was demonstrated in another study of hepatic IR injury (Llacuna et al., 2006). 
Hepatic ceramide transiently increased after the reperfusion phase due to activation of 
aSMase followed by acid ceramidase stimulation. Knocking down aSMase by in vivo 
administration of siRNA decreased ceramide generation during IR, and attenuated 
hepatocellular necrosis, cytochrome c release, and caspase-3 activation. The study draws 
attention to an important role of ceramide in IR-induced liver damage and suggests that 
modulation of aSMase could be of therapeutic relevance in liver transplantation.  
4.3 Kidney ischemia  
In the whole kidney IR model, ceramide content was increased about 1.8-fold in the injured 
tissue during the reperfusion phase (Zager et al., 1997) which was not accompanied by SM 
hydrolysis.  In fact, there was no SM content change in post-IR tissue. Analysis of SMase 
activity revealed that ischemia induced declines (50%) in both acid and neutral SMase 
activity, and these persisted throughout the 24-h reperfusion period (Zager et al., 1998). 
C16:0-, C22:0-, and C24:0-ceramides comprised 20%, 10%, and 70% of the total ceramide content 
in kidney tissue, respectively (Kalhorn and Zager, 1999). IR dramatically increased C16:0-
ceramide (4-fold), and all other ceramides increased modestly. Interestingly, IR induced a 
striking shift towards unsaturated (vs. saturated) fatty acyl within C22:0- and C24:0- (but not 
C16:0-) ceramide pools. The data imply that IR-induced inhibition of sphingomyelin 
hydrolysis results in accumulation of ceramide, the substrate in sphingomyelin synthetic 
pathway. 
4.4 Cerebral ischemia  
Ischemic stroke occurs when cerebral or precerebral arteries are occluded or significantly 
stenosed by emboli or by local atherosclerotic disease. Within minutes of interrupted blood 
flow, mitochondrial energy production is shut down due to lack of oxygen resulting in 
membrane depolarization and excessive release of neurotransmitters, specifically, 
glutamate. Extracellular glutamate accumulation over-stimulates glutamate receptors, 
www.intechopen.com
 
Advances in the Preclinical Study of Ischemic Stroke 
 
278 
promoting cytosolic Ca2+ overload, the generation of ROS, and mitochondrial dysfunction 
leading to cell death.  
A few studies reported ceramide accumulation during cerebral ischemia and IR (Kubota et 
al., 1989; Nakane et al., 2000), and it appears that the mechanism of ceramide accumulation 
depends on the severity of the insult to the brain. Thus, severe and lethal cerebral IR 
resulted in ceramide accumulation via activation of aSMase and SM hydrolysis (Kubota et 
al., 1989; Kubota et al., 1996; Nakane et al., 2000) or inhibition of ceramide utilization by 
glucosylceramide synthase (Takahashi et al., 2004). Consistent with these data, the extent of 
brain tissue damage was decreased in mice lacking aSMase (Yu et al., 2000). In a recent 
study, severe cerebral IR induced SM hydrolysis and increased ceramide and sphingosine in 
the ischemic brain (Chudakova et al., 2008). Similarly, chronic cerebral ischemia caused 
ceramide accumulation due to activation of SM degradation accompanied by reduced 
ceramide utilization via glucosylceramide synthase (Ohtani et al., 2004). The data highlight 
IR-induced deregulation of complex sphingolipids metabolism. 
In mild IR, ceramide accumulation resulted from de novo ceramide biosynthesis rather from 
hydrolysis of SM (Yu et al., 2007). There is apparent tissue specificity in the expression of 
individual ceramide species that might reflect the tissue specificity of the ceramide 
synthases. In brain, C18:0-, C18:1- and C24:1-ceramide are the major species expressed (39.5%, 
34%, and 12.5% of total ceramide, respectively) whereas C16:0- ceramide contributes only 4% 
of total ceramide. All ceramide species were elevated in the ischemic brain about 1.5–2-fold. 
The enhanced accumulation of sphingolipids seems to occur during the reperfusion phase; 
there were no changes in sphingolipid content after ischemia without reperfusion. This 
finding is in line with data which show that both ischemia and the restoration of blood flow 
to ischemic tissue (reperfusion) causes cellular damage by different molecular mechanisms 
(Chan, 2004; Gustafsson and Gottlieb, 2008).  
Investigation of intracellular sites of ceramide accumulation after mild IR revealed the 
elevation of ceramide species both in purified mitochondria and in the ER (Yu et al., 2007). 
In mitochondria, only C18:0-, C18:1- and C16:0-ceramides were increased, but all ceramide 
species increased in the ER suggesting activation of different ceramide synthases in these 
intracellular compartments. Indeed, several ceramide synthases were identified in 
mitochondria and the ER, including CerS1, CerS2, and CerS6, but CerS5 was localized only 
in the ER in the brain. Activity measurements indicated activation of CerS6 in ischemic 
mitochondria apparently via post-translational mechanisms; IR did not affect the CerS6 
protein expression (Yu et al., 2007).  
It appears that CerS6 is developmentally regulated and primarily generates C16:0-ceramide 
in brain mitochondria (Novgorodov et al., 2011a). An investigation into the role of CerS6 in 
mitochondria revealed that ceramide synthase down-regulation during brain development 
is associated with dramatically decreased mitochondrial Ca2+-loading capacity (CLC) which 
could be rescued by addition of ceramide. Ceramide-mediated blockade of MPTP opening 
seems to be the underlying mechanism of the increased CLC in brain mitochondria isolated 
from young animals. In fact, mitochondria maintain low cytosolic Ca2+ levels by 
sequestering Ca2+ inside the mitochondrial matrix complexed with phosphate. Energized 
mitochondria take up Ca2+ via the mitochondrial calcium uniporter which has been recently 
described as a highly selective, inwardly rectifying channel (Kirichok et al., 2004). Excessive 
accumulation of Ca2+ in the mitochondrial matrix could trigger opening of MPTP at a high 
conductance state, which would be accompanied by dissipation of the transmembrane 
potential and mitochondrial swelling. In brain mitochondria, Ca2+ may also activate a 
www.intechopen.com
 
Mitochondrial Ceramide in Stroke 
 
279 
limited permeability state of MPTP opening (Novgorodov and Gudz, 1996) that only 
depolarizes mitochondria without causing swelling (Brustovetsky and Dubinsky, 2000b). 
This depolarization dramatically reduces the driving force for Ca2+ influx via mitochondrial 
Ca2+ uniporter , thus limiting the mitochondrial ability to sequester Ca2+(Brustovetsky and 
Dubinsky, 2000a). The lower CerS6 expression and C16:0-ceramide content were associated 
with reduced mitochondrial CLC in adult brain mitochondria, whereas exogenous C16:0-
ceramide restored CLC to that of young brain mitochondria. This is in line with the finding 
that long-chain ceramides, including C16:0-ceramide, are potent inhibitors of MPTP activity 
(Novgorodov et al., 2008). This suggests that CerS6-generated ceramide could prevent 
MPTP opening, leading to increased Ca2+ accumulation in the mitochondrial matrix. 
The role of CerS6 in cell survival was examined in primary oligodendrocyte (OL) precursor 
cells, which undergo apoptotic cell death during early postnatal brain development or 
following cerebral IR. Exposure of OLs to glutamate resulted in apoptosis that was 
prevented by inhibitors of de novo ceramide biosynthesis, myriocin and fumonisin B1. 
Knockdown of CerS6 with siRNA reduced glutamate-triggered OL apoptosis, whereas 
knockdown of CerS5 had no effect. Importantly, blocking mitochondrial Ca2+ uptake or 
decreasing Ca2+-dependent protease calpain activity with specific inhibitors prevented OL 
apoptosis. Finally, knocking down CerS6 decreased calpain activation. The data suggest a 
novel role for CerS6 in the regulation of both mitochondrial Ca2+ homeostasis and calpain, 
which could be important in cell death after cerebral IR (Scheme 3). These studies illuminate 
a novel determinant in cerebral IR, mitochondrial ceramide synthase CerS6 which could be 
an important future target for neuroprotection. 
In vitro, de novo synthesized ceramide increased after brief exposure of cultured brain cells to 
hypoxia, oxygen/glucose deprivation, or TNF (Ginis et al., 1999; Liu et al., 2000). In 
neuronal precursor cells, hypoxia/reoxygenation triggered a robust elevation in C14:0- and 
C16:0-ceramides, and a small increase in C18:0-, C18:1- and C20:0-ceramides, and no increase in 
C24:0- and C24:1-ceramides (Jin et al., 2008). The elevations in ceramides were primarily due to 
the actions of aSMase and ceramide synthase CerS5, demonstrating the involvement of the 
salvage pathway. Interestingly, C2-ceramide infusion protected the brain against IR injury 
(Chen et al., 2001; Furuya et al., 2001). However, this effect could be also attributed to the 
intracellular/extracellular conversion of ceramide into sphingosine-1-phosphate, which is 
known to protect cells from apoptosis (Hait et al., 2006; Taha et al., 2006; Tani et al., 2007). 
5. Ceramide and mitochondrial injury in stroke 
Although IR–induced mitochondrial injury has been extensively studied and mitochondrial 
functions affected by IR are characterized (Sims and Anderson, 2002), crucial information is 
needed regarding the cause of mitochondrial dysfunction. Our studies suggest that 
exogenously added ceramide could provoke mitochondrial dysfunctions similar to that 
occurring in cerebral IR (Yu et al., 2007). Of note, some data on mitochondrial effects of 
ceramide have been obtained using synthetic short-chain analogs, which may not fully 
mimic the properties of naturally occurring long-chain ceramides. 
5.1 Respiratory chain  
The restriction on mitochondrial respiratory chain function has been shown in various 
rodent models of stroke (Sims and Anderson, 2002). An impairment of Complex III has been  
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Scheme 3. Hypothetical role of CerS6/ceramide in mitochondria after cerebral IR. IR triggers 
glutamate-induced cytosolic Ca2+ influx into the mitochondria and an activation of 
mitochondrial CerS6 that elevates ceramide. Ceramide blocks the MPTP opening at a low 
conductance state, leading to increased Ca2+ in the mitochondrial matrix. This MPTP 
inactivation would allow mitochondria to support adequate ATP production for formation 
of the apoptosome, and might be responsible for the initial raise in ATP production (and 
hence Δψ) during apoptosis (Atlante et al., 2005), an observation that corresponds well with 
the reported transient mitochondrial hyper-polarization in the apoptosis induced by IL-3 
withdrawal (Vander Heiden et al., 1997).  Rising mitochondrial Ca2+ activates calpain 10, 
which could cleave protein components of the MPTP (Arrington et al., 2006) resulting in the 
MPTP opening at a high conductance state, swelling, and rupture of the outer mitochondrial 
membrane leading to necrotic cell death. 
implicated (Scheme 4), but the mechanisms remain unresolved, and a Complex I defect has 
not been ruled out. We and others have reported that short-chain ceramide could directly 
suppress respiratory chain Complex III activity (Di Paola et al., 2000; Gudz et al., 1997). 
Also, ceramide seems to participate in displacement of cytochrome c from its binding site on 
Complex III (Yuan et al., 2003) corresponds to an apparent mitochondrial Complex III defect 
in IR.  
5.2 Reactive Oxygen Species (ROS) 
Free radical formation occurs during cerebral IR. In fact, mitochondria are the major site of 
production of ROS, and are the likely source for the generation of peroxynitrite, formed from 
nitric oxide and superoxide during IR (Chan, 2001). Studies in isolated mitochondria indicated 
that Complex I and III are potential sites of superoxide formation (Votyakova and Reynolds, 
2001). Complex III deficiency observed in cerebral IR strongly implicates Complex III as the 
major and relevant site of ROS generation; however, Complex I remains to be ruled out. Short-
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chain ceramide could increase the generation of ROS in isolated mitochondria (Garcia-Ruiz et 
al., 1997).  
 
Complex I
Glutamate
Complex II
Succinate
Complex III
Cytochrome c
Ascorbate
Complex IV O2
ROS
ROS
 
Scheme 4. Mitochondrial respiratory chain complexes. Mitochondrial respiratory chain 
consists of four multi-protein complexes Complex I-IV. The respiratory chain function is 
determined using substrates such as glutamate, succinate or ascorbate, which are oxidized 
via different complexes of respiratory chain. An inhibition of the electron transport through 
the Complex I or III could result in generation of ROS. 
5.3 Mitochondrial Permeability Transition Pore (MPTP)  
Excessive accumulation of Ca2+ in mitochondrial matrix could trigger opening of the MPTP 
at a high conductance state that is accompanied with dissipation of transmembrane 
potential and swelling of mitochondria. In brain mitochondria, Ca2+ may also activate a 
limited permeability state of MPTP opening that only depolarizes mitochondria without 
swelling (Novgorodov and Gudz, 1996). This depolarization dramatically reduces the 
driving force for Ca2+ influx via the uniporter channel in the inner membrane, thus limiting 
the mitochondrial ability to sequester Ca2+.  
MPTP opening at a high conductance state appears to be a crucial event leading to cell death 
by necrosis (Fiskum, 2000; Galluzzi et al., 2009; Kroemer et al., 1998).  Severe insult causes 
widespread opening of the MPTP in mitochondria. Cell death proceeds through necrosis when 
the MPTP remains open, causing the inhibition of ATP production. If the initial insult is not 
too severe and MPTP does not open, cellular ATP can be maintained to support the energy 
demand of apoptosis. This provides an explanation for the coexistence of apoptotic and 
necrotic cell death in IR-injured tissue. It has been emphasized that MPTP regulates necrotic, 
but not apoptotic cell death in cardiac and cerebral IR (Nakagawa et al., 2005; Schinzel et al., 
2005). Mice deficient in cyclophilin D (CyD), the main regulatory component of MPTP, 
developed up to 37% smaller brain infarcts after IR. CyD-deficient cells died normally in 
response to various apoptotic stimuli, but were resistant to necrotic cell death induced by ROS 
and Ca2+ overload. MPTP opening at a high conductance state has been proposed to occur in 
cerebral IR, but the evidence is largely indirect (Sims and Anderson, 2002; Stavrovskaya and 
Kristal, 2005). The opening of the MPTP at a high conductance state has been implicated as 
another mechanism of cytochrome c release from mitochondria due to short-chain ceramide 
(Arora et al., 1997; Novgorodov et al., 2005; Pastorino et al., 1999a; Szalai et al., 1999).  
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5.4 Release of pro-apoptotic proteins from mitochondria 
Apoptosis is mediated by two major pathways: the extrinsic and the intrinsic (or 
mitochondrial) pathway. The release of mitochondrial cytochrome c and/or Smac, which 
antagonizes apoptotic protein inhibitor, into the cytosol initiates the activation of caspase-9 
leading to the proteolytic activation of executioner caspase-3 and -7. Cytochrome c release 
from mitochondria is well documented in different models of ischemia (Galluzzi et al., 
2009). Recent studies have showed caspase-independent apoptosis involving the release of 
mitochondrial proteins, apoptosis-inducing factor (AIF), and endonuclease G (EndoG) and 
their translocation to the nucleus in brain IR (Galluzzi et al., 2009; Joza et al., 2009). 
Emerging evidence indicates an important role of Bax in cytochrome c and Smac (but not 
AIF and EndoG) release from brain mitochondria (Brustovetsky et al., 2003). Importantly, 
mitochondrial calpain has been implicated in AIF release from mitochondria (Kar et al.). The 
release of mitochondrial proteins implies that the outer and /or the inner mitochondrial 
membrane is compromised in IR, but the precise mechanisms of the protein release remain 
unclear. Short-chain ceramide accelerated the release of cytochrome c and AIF from heart 
mitochondria (Di Paola et al., 2004), and natural C16-ceramide has been shown to form large 
channels in the outer mitochondrial membrane permeable to cytochrome c (Siskind and 
Colombini, 2000). 
6. Ceramide and mitochondria in cell death 
Irrespective of the type of IR, IR-related physiological events have a common final 
consequence: alteration of mitochondrial function and release of mitochondrial proteins, 
leading to cell death. Cells with hallmarks of necrosis or apoptosis have been detected in 
animal models of IR (Li et al., 1995). The mitochondrial changes appear to be one essential 
step in tissue damage in IR, and treatments that ameliorate tissue infarction were associated 
with better recovery of mitochondrial function (Nakai et al., 1997). Multiple studies show 
intimate connections between ceramide signaling and functioning of mitochondria 
(Mimeault, 2002; Morales et al., 2007), which play central role in integration of cellular 
signals to determine the outcome among apoptosis, necrosis, or proliferation (Brenner and 
Kroemer, 2000; Ferri and Kroemer, 2001; Kroemer et al., 2007).  
 Several lines of evidence have implicated changes in mitochondrial function as an 
intermediate step in transduction of ceramide signals that culminate in apoptotic or necrotic 
cell death (Morales et al., 2007; Taha et al., 2006). First, ceramide-induced apoptosis is 
accompanied by release of pro-apoptotic proteins from mitochondria (Birbes et al., 2001; 
Hearps et al., 2002; Zhang et al., 2008), increased generation of mitochondrial ROS (Won and 
Singh, 2006), and discharge of mitochondrial transmembrane potential, ∆ψ (Gendron et al., 
2001; Hearps et al., 2002; Lin et al., 2004; Zamzami et al., 1995). Second, interventions that 
specifically prevent mitochondrial dysfunction suppress ceramide-induced apoptosis: 
inhibitors of the MPTP bongkrekic acid (Gendron et al., 2001; Stoica et al., 2003) and 
cyclosporin A (Pacher and Hajnoczky, 2001; Pastorino et al., 1996; Stoica et al., 2003); and 
over-expression of Bcl-2 (Geley et al., 1997; Gendron et al., 2001; Scaffidi et al., 1999; 
Zamzami et al., 1995; Zhang et al., 1996). Third, TNF-α-, ischemia/reperfusion-, etoposide-, 
or UV-induced apoptosis is associated with simultaneous increase in mitochondrial 
ceramide (Birbes et al., 2005; Dai et al., 2004; Garcia-Ruiz et al., 1997; Yu et al., 2007).   
Depending on cell type and stimuli, ceramide can alter mitochondrial function indirectly or 
directly (Scheme 5). Indirectly, ceramide modifies activity of pro-apoptotic and anti-
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apoptotic members of the Bcl-2 family of proteins that, in turn, alter the outer mitochondrial 
membrane permeability for cytochrome c and other pro-apoptotic molecules. Protein targets 
for ceramide in the cytoplasm include protein phosphatases PP1A and PP2A, protein 
kinases PKC ζ, raf-1, and kinase-suppressor Ras (Snook et al., 2006). In the lysosomal 
compartment, ceramide activates aspartate protease cathepsin D (Bidere et al., 2003; 
Heinrich et al., 2004; Heinrich et al., 1999; Pettus et al., 2002). Among these targets, cathepsin 
D, PP2A, and PP1A could propagate a pro-apoptotic ceramide signal to the level of the 
mitochondria (Pettus et al., 2002). Interaction of ceramide with cathepsin D results in 
cleavage of Bid to active tBid with subsequent activation of caspase-9 and caspase-3 
(Heinrich et al., 2004). Activation by ceramides of serine/threonine protein phosphatase 
PP2A is involved in regulation of the apoptotic/anti-apoptotic activity of Bcl-2 family 
proteins by changing their phosphorylation status. Ceramide-activated PP2A increases the 
pro-apoptotic potential of Bcl-2 family proteins by dephosphorylation of Bax (activation) 
(Xin and Deng, 2006), or Bcl-2 (inactivation) (Ruvolo et al., 1999). An additional substrate for 
PP2A is serine/threonine kinase Akt/PKB (Pettus et al., 2002). Ceramide-dependent 
activation of PP2A leads to inactivation of Akt (Garcia et al., 2003; Millward et al., 1999; 
Pettus et al., 2002) that, in turn, results in dephosphorylation and activation of pro-apoptotic 
Bad, an Akt substrate (Datta et al., 1997). At the same time PP2A can directly 
dephosphorylate Bad, thus increasing its pro-apoptotic activity (Chiang et al., 2003). PP1A 
also can exert its effect on mitochondria by Bad dephosphorylation (Garcia et al., 2003). 
Interestingly, ceramide by itself can trigger transition of Bax into the active conformation, 
insertion in to the outer mitochondrial membrane with the subsequent release of 
cytochrome c and Smac in a cell-free system (Kashkar et al., 2005). Potentiation of Bax 
binding by ceramides to the outer mitochondrial membrane was shown by Birbes and 
colleagues (Birbes et al., 2005) and in energized mitochondria ceramide-induced Bax-
dependent MPTP opening (Pastorino et al., 1999b). Critical involvement of ceramide in 
triggering Bax translocation to the mitochondria was demonstrated during 
hypoxia/reoxygenation in neuronal cells (Jin et al., 2008). Attenuation of Bax translocation 
by knockdown of ceramide synthase CerS5 or aSMase suggests contribution of the activated 
salvage pathway in ceramide upregulation; however, the mechanisms by which ceramide 
exerts its effect remain unknown.  
Less-defined, indirect mechanisms include interaction of ceramide with protein kinases PKC 
δ, p38 and JNK. Short-chain ceramides induce translocation of PKC δ from the cytoplasm to 
the mitochondria in LNCaP cells (Sumitomo et al., 2002). The translocation of PKC δ was 
accompanied by cytochrome c release. Mitochondrial translocation of PKC δ and activation 
of kinase activity was also evident when endogenous ceramides were raised by activation of 
de novo and neutral SMase-dependent pathways of ceramide production. Endogenous 
ceramide-induced PKC δ translocation similarly promoted release of cytochrome c and 
caspase-9 activation. A report by Huwiler et al. (Huwiler et al., 1998) indicates that ceramide 
can directly target PKC δ. Thus, increased ceramide during I/R can potentially contribute to 
mitochondrial translocation/activation of PKC δ, which enhances cytochrome c release in 
heart I/R (Murriel et al., 2004). Although potential mitochondrial PKC δ targets for which 
phosphorylation results in cytochrome c release remain illusive, PKC δ-dependant 
accumulation and dephosphorylation of Bad may contribute to the initiation of apoptotic 
program (Murriel et al., 2004).  
The member of the mitogen-activated protein kinase (MAPK) superfamily p38 MAPK was 
implicated in ceramide-induced apoptosis in cardiomyocytes (Kong et al., 2005). Short-chain  
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Scheme 5. Ceramide modulates mitochondrial functions through direct and indirect 
mechanisms. A. Indirect modulation of mitochondrial functions by ceramide occurs through 
the change in the ratio of pro-apoptotic/anti-apoptotic proteins of Bcl-2 family at the outer 
mitochondrial membrane. B. Direct modulation of mitochondrial functions by ceramide 
include a) formation of ceramide channels permeable for cytochrome c in the outer 
mitochondrial membrane; b) potentiation of mitochondrial permeability transition pore 
opening (MPTP) in the inner membrane in the presence of Ca2+ or Bax (ceramide-induced 
Ca2+ release from the endoplasmic reticulum (ER) can contribute to the processes; c) 
potentiation of Bax insertion (activation) in to the outer membrane, d) inhibition of the 
respiratory chain (RC) with a subsequent increase in ROS formation. 
ceramide treatment induced phosphorylation/activation of p38 MAPK which was 
accompanied by release of cytochrome c from the mitochondria and by the discharge of 
mitochondrial membrane potential. P38 MAPK inhibitor, SB 202190, abrogated the effect of 
ceramide both on p38 MAPK phosphorylation and on mitochondrial dysfunction. An 
interesting aspect of the study was the phosphorylation of the mitochondria-associated p38 
MAPK pool under the influence of ceramide. This observation might indicate local signaling 
in mitochondria-mediated cell death. Although mitochondria-related targets for ceramide-
activated p38 MAPK are not well defined, a recent report by Capano and Crompton 
(Capano and Crompton, 2006) demonstrates that activation of p38 MAPK during simulated 
ischemia in cardiomyocytes is a key regulatory point of Bax translocation from the cytosol to 
the mitochondria. The evidence of p38 MAPK-dependent phosphorylation of BimEL in 
apoptotic cell response has been provided (Cai et al., 2006) . Another member of the MAPK 
superfamily, JNK, was shown to be readily activated by both endogenous ceramide 
generation in liver I/R (Llacuna et al., 2006) and by addition of exogenous ceramide 
(Kurinna et al., 2004). Activated JNK translocates to the mitochondria and initiates 
cytochrome c release and cell death by yet unidentified mechanisms (Eminel et al., 2004; 
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Kurinna et al., 2004); however, direct interaction of JNK with the mitochondrial pool of Bcl-
xL was suggested (Kharbanda et al., 2000). Alternatively, activated JNK can induce 
mitochondrial dysfunction by phosphorylation of a pro-apoptotic member of the Bcl-2 
family protein, Bim (Kurinna et al., 2004; Lei and Davis, 2003; Llacuna et al., 2006). 
Translocation of activated Bim to mitochondria initiates Bax-dependent cytochrome c 
release and apoptosis (Lei and Davis, 2003). Several other members of Bcl-2 family proteins 
have been proposed to mediate pro-apoptotic JNK signaling(Weston and Davis, 2007). 
Overall, the increased ratio of pro-apoptotic/anti-apoptotic proteins bound to mitochondria 
is generally considered to trigger permeabilization of the outer mitochondrial membrane for 
cytochrome c and other mitochondrial inter-membrane resident proteins, initiators of 
apoptosis (Armstrong, 2006; Kroemer et al., 2007). The increases in cell ceramide species 
contents are expected to contribute to the induction of apoptosis by this mechanism.  
Among non-protein indirect pathways, those associated with Ca2+ signaling attract special 
attention because of the well-known ability of these organelles both to respond to Ca2+ and 
to shape and propagate the Ca2+ signal within the cell (Giorgi et al., 2008; Szabadkai and 
Duchen, 2008). In this pathway, the Ca2+ pool of the ER is a target for ceramide (Pinton et al., 
2001; Scorrano et al., 2003). Ca2+ released by ceramide from the ER is readily accumulated in 
mitochondria that, in turn, results in MPTP opening, and cytochrome c release.  
Evidence is also accruing to implicate a direct action of ceramide on mitochondria. In this 
context, modulation by ceramide of mitochondrial functions at the level of isolated 
organelles has provided further evidence in support of this mechanism. It has been reported 
that ceramides directly suppress respiratory chain activity at the level of respiratory chain 
Complex III and/or Complex I (Di Paola et al., 2000; Garcia-Ruiz et al., 1997; Gudz et al., 
1997; Yu et al., 2007). Suppression of the respiratory chain by ceramides results in increased 
production of ROS (Andrieu-Abadie et al., 2001; Di Paola et al., 2000; Garcia-Ruiz et al., 
1997; Quillet-Mary et al., 1997), well-known inducers of an apoptotic cell response (Andrieu-
Abadie et al., 2001; Ott et al., 2007). Increased ROS production by endothelial cells after 
hypoxia/reoxygenation was linked to the ceramide-induced suppression of the 
mitochondrial respiratory chain (Therade-Matharan et al., 2005). 
Moreover, current research is focused on the ability of ceramides to release cytochrome c or 
other pro-apoptotic proteins from the mitochondrial inter-membrane space. Within the 
model of Colombini and co-workers, pro-apoptotic protein release is due to formation of 
large pores in the outer mitochondrial membrane by ceramide itself, whereas the inner 
membrane is viewed as being ceramide-insensitive. This model is supported by extensive 
experimental material using isolated mitochondria (Di Paola et al., 2004; Ghafourifar et al., 
1999; Siskind et al., 2002, 2006) and artificial membranes (liposomes and black lipid 
membranes) (Montes et al., 2002; Siskind et al., 2002). Importantly, it was recently shown 
that anti-apoptotic Bcl-2 can disassemble ceramide channels in the outer mitochondrial 
membrane and black lipid membranes (Siskind et al., 2008), thus providing the mechanistic 
explanation for the original observation of Ghafourifar et al. (Ghafourifar et al., 1999) that 
Bcl-2 suppresses ceramide-induced cytochrome c release from isolated mitochondria. 
However, the formation of ceramide channels seems to be highly dependent on the 
conditions employed, and has been questioned in a number of publications (Kristal and 
Brown, 1999; Novgorodov et al., 2005; Szalai et al., 1999; Yuan H, 2003). Besides, a few 
reports suggest that the permeabilization of the inner mitochondrial membrane via the 
opening of the MPTP could be a primary event in initiation of cytochrome c release in the 
presence of ceramides (Pastorino et al., 1999b; Szalai et al., 1999). The switch between 
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selective permeabilization of the outer membrane vs. permeabilization of the inner 
membrane in the presence of ceramide appears to depend on the composition of incubation 
medium and the nature of ceramide employed (Di Paola et al., 2004).  
Additional direct effects of ceramide on mitochondria include modulation of the ionic 
permeability of the lipid component of the inner membrane (Di Paola et al., 2000) and 
displacement of cytochrome c from the inner membrane as a result of the direct interaction 
with the proteins in the respiratory chain Complex III (Ghafourifar et al., 1999; Yuan H, 
2003). Emerging evidence suggests involvement of ceramides in reorganization of the 
mitochondrial network. Both exogenous and endogenously generated ceramides induce 
mitochondrial fission (Parra et al., 2008; Zeidan et al., 2008), which may contribute to 
apoptotic cell death (Suen et al., 2008). What particular effectors of mitochondrial fission 
(DRP1, Fis1, or Bax) or fusion (OPA-1, Mitofusins) machineries are the targets of ceramide in 
this process remains to be determined. However, in cardiomyocytes exposed to exogenous 
C2-ceramide, an increased expression of mitochondrial resident Fis1 and enhanced 
recruitment of cytosolic DRP1 to mitochondrial fission foci may contribute to disintegration 
of the mitochondrial network (Parra et al., 2008).  
It should be appreciated that the ceramide/mitochondria interaction in the control of 
apoptosis should be considered in conjunction with the effects of its pro-apoptotic 
metabolites such as ganglioside GD3 and sphingosine. GD3 shares with ceramide the same 
properties with respect to its effects on isolated mitochondria and mitochondria in situ. In 
cells, it disrupts mitochondrial membrane potential in a Bcl-2-sensitive manner (Rippo et al., 
2000) and induces ROS production (Colell et al., 2001). At the level of isolated mitochondria, 
it inhibits the mitochondrial respiratory chain at the level of Complex III (Scorrano et al., 
1999), increases ROS production (Garcia-Ruiz et al., 2000), opens the MPTP with the 
subsequent release of cytochrome c (Inoki et al., 2000; Kristal and Brown, 1999; Scorrano et 
al., 1999), and potentiates interaction of Bax with mitochondria (Pastorino et al., 1999b). 
Interestingly, while the effect of CD3 on ROS production is relatively nonspecific 
(lactosylceramide, GM1, GD1a and glucosylceramide produce a similar response (Garcia-
Ruiz et al., 1997)), the effect of GD3 in the induction of apoptosis and MPTP opening shows 
considerable specificity. GM3, GM1 GD1, GD1a, GT1 has no or a slight inhibitory effect 
(Kristal and Brown, 1999; Pastorino et al., 1999b; Scorrano et al., 1999). In some instances, the 
effect of ceramide on mitochondria in cells can be explained by its conversion to GD3 (De 
Maria et al., 1997; Rippo et al., 2000).  
Another pro-apoptotic ceramide derivative, sphingosine, releases cytochrome c from 
mitochondria that could be inhibited by over-expression of anti-apoptotic Bcl-xL (Cuvillier 
et al., 2000). In contrast to ceramides and GD3, sphingosine suppresses the MPTP in isolated 
mitochondria, and thus MPTP-dependent cytochrome c release (Broekemeier and Pfeiffer, 
1995; Scorrano et al., 2001). It also inhibits ceramide channel formation in the outer 
mitochondrial membrane (Elrick et al., 2006). This indicates that indirect pathways of 
cytochrome c release, for example, by recruitment of Bax to mitochondria (Phillips et al., 
2007), are predominant in the action of sphingosine on mitochondria. At the same time, 
similar to ceramide, sphingosine suppresses respiratory chain activity (Hassoun et al., 2006) 
and increases ROS production by mitochondria, although at higher concentrations (Garcia-
Ruiz et al., 1997). Interaction of ceramide, sphingosine, and ganglioside pathways in the 
control of mitochondrial functions in the time-course of apoptosis remains to be established. 
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Thus, the proposed mechanisms by which ceramides may affect mitochondria vary, and the 
combination of direct and indirect mechanisms involved in propagation of ceramide signals 
to mitochondria depends on cell type and the nature of the stimuli employed.  
7. Conclusion 
A cardinal feature of brain tissue injury in stroke is mitochondrial dysfunction and the 
release of mitochondrial proteins leading to cell death.  It has become increasingly clear that 
ceramide, a membrane sphingolipid and a key mediator of cell-stress responses, could play 
a critical role in cerebral IR - induced mitochondrial injury. Mitochondria are being 
appreciated as vital intracellular compartments for ceramide metabolism in cerebral IR. 
Emerging data suggest that the subcellular location of ceramide generation plays a 
fundamental role in dictating its downstream targets and cell responses to stress stimuli. 
Continued research efforts are required to better understand the pathophysiological 
mechanisms of cerebral IR injury, to identify and test new protective agents. Further studies 
of the molecular basis of the role of ceramide in the ischemic brain are warranted. Because 
many assumptions regarding ceramide functions in IR-induced tissue injury were based on 
in vitro studies employing artificial ceramides, we must critically evaluate the mitochondrial 
dysfunctions in IR-injured brain and define a possible role of long-chain ceramides as causes 
of the mitochondrial impairment. This will allow the discovery of novel and 
groundbreaking therapeutic approaches to mitigate diseases that may result from elevations 
in ceramide and its metabolites. 
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